Beneficient (NASDAQ:BENF – Get Free Report) was the target of a large decline in short interest in January. As of January 15th, there was short interest totaling 107,656 shares, a decline of 22.6% from the December 31st total of 139,093 shares. Approximately 0.8% of the company’s shares are short sold. Based on an average daily volume of 57,662 shares, the short-interest ratio is presently 1.9 days. Based on an average daily volume of 57,662 shares, the short-interest ratio is presently 1.9 days. Approximately 0.8% of the company’s shares are short sold.
Wall Street Analysts Forecast Growth
Several research analysts recently commented on the stock. Wall Street Zen upgraded shares of Beneficient to a “sell” rating in a report on Saturday, November 1st. Weiss Ratings reissued a “sell (e+)” rating on shares of Beneficient in a research note on Monday, December 29th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Beneficient presently has a consensus rating of “Sell”.
View Our Latest Research Report on Beneficient
Beneficient Stock Performance
About Beneficient
Beneficient, a technology-enabled financial services company, provides liquidity solutions and related trustee, custody and trust administrative services to participants in the alternative asset industry in the United States. It operates through Ben Liquidity, Ben Custody, and Customer ExAlt Trusts segments. The company offers Ben AltAccess platform for secure, online, and end-to-end delivery of each of the Ben business unit products and services, including upload documents, and work through tasks, and complete their transactions with standardized transaction agreements.
Further Reading
- Five stocks we like better than Beneficient
- The day the gold market broke
- Forget AI, This Will Be the Next Big Tech Breakthrough
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- ALERT: Drop these 5 stocks before the market opens tomorrow!
- End of America Update
Receive News & Ratings for Beneficient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beneficient and related companies with MarketBeat.com's FREE daily email newsletter.
